Cargando…

Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study

Background. Although human immunodeficiency virus (HIV)-positive persons on antiretroviral therapy (ART) frequently have chronic liver enzyme elevation (cLEE), the underlying cause is often unclear. Methods. Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study participants without chron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kovari, Helen, Sabin, Caroline A., Ledergerber, Bruno, Ryom, Lene, Reiss, Peter, Law, Matthew, Pradier, Christian, Dabis, Francois, d'Arminio Monforte, Antonella, Smith, Colette, de Wit, Stephane, Kirk, Ole, Lundgren, Jens D., Weber, Rainer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767274/ https://www.ncbi.nlm.nih.gov/pubmed/26925429 http://dx.doi.org/10.1093/ofid/ofw009

Ejemplares similares

Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study
por: Hatleberg, Camilla I, et al.
Publicado: (2018)

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2014)

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration
por: Sabin, Caroline A., et al.
Publicado: (2016)

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study()
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2019)

Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals: Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study
por: Worm, Signe W., et al.
Publicado: (2009)

Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study
por: Smith, Colette, et al.
Publicado: (2014)

A comparison of estimated glomerular filtration rates using Cockcroft−Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection
por: Mocroft, A, et al.
Publicado: (2014)

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
por: Boettiger, David C, et al.
Publicado: (2021)

Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
por: Petoumenos, Kathy, et al.
Publicado: (2012)

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
por: Boyd, Mark A., et al.
Publicado: (2017)

645 Structural Bone Deficits in HIV/HCV, HCV-Monoinfected, and HIV-Monoinfected Women
por: Lo Re, Vincent, et al.
Publicado: (2014)

HIV-Infected Late Presenter Patients
por: D'Arminio Monforte, Antonella, et al.
Publicado: (2012)

Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
por: Lodi, S, et al.
Publicado: (2010)

Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co‐infected HIV patients with cirrhosis
por: Willemse, Sophie, et al.
Publicado: (2019)

Prevalence and risk factors for patient-reported joint pain among patients with HIV/Hepatitis C coinfection, Hepatitis C monoinfection, and HIV monoinfection
por: Ogdie, Alexis, et al.
Publicado: (2015)

Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA
por: Ryom, L, et al.
Publicado: (2010)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

Clinical management of ageing people living with HIV in Europe: the view of the care providers
por: Boffito, Marta, et al.
Publicado: (2020)

Correction to: Clinical management of ageing people living with HIV in Europe: the view of the care providers
por: Boffito, Marta, et al.
Publicado: (2020)

The Challenge of Interpreting Alanine Aminotransferase Elevations in Clinical Trials of New Drug Candidates
por: Church, Rachel J., et al.
Publicado: (2020)

Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
por: Kobayashi, Daiki, et al.
Publicado: (2021)

A clinically useful risk-score for chronic kidney disease in HIV infection
por: Mocroft, Amanda, et al.
Publicado: (2014)

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study
por: Kamara, David A, et al.
Publicado: (2014)

Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis
por: Girardi, Enrico, et al.
Publicado: (2012)

The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
por: Weng, Stephen F, et al.
Publicado: (2015)

Remdesivir: Elevated aspartate aminotransferase and alanine aminotransferase levels: case report
Publicado: (2022)

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
por: Grady, Bart P. X., et al.
Publicado: (2016)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV
por: Greenberg, Lauren, et al.
Publicado: (2023)

Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?
por: Tincati, Camilla, et al.
Publicado: (2020)

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
por: Mocroft, Amanda, et al.
Publicado: (2013)

Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature
por: Tincati, Camilla, et al.
Publicado: (2018)

Evaluation of drug-induced tissue injury by measuring alanine aminotransferase (ALT) activity in silkworm hemolymph
por: Inagaki, Yoshinori, et al.
Publicado: (2012)

Elevated alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus coinfection
por: Alghamdi, Saad, et al.
Publicado: (2016)

Caring for women living with HIV: gaps in the evidence
por: Loutfy, Mona R, et al.
Publicado: (2013)

Aspartate Aminotransferase (AST/GOT) and Alanine Aminotransferase (ALT/GPT) Detection Techniques
por: Huang, Xing-Jiu, et al.
Publicado: (2006)

Alanine aminotransferase controls seed dormancy in barley
por: Sato, Kazuhiro, et al.
Publicado: (2016)

Alanine Aminotransferase Level: The Road to Normal in 2021
por: Yip, Terry Cheuk‐Fung, et al.
Publicado: (2021)

Illness Representations of HIV Positive Patients Are Associated with Virologic Success
por: Leone, Daniela, et al.
Publicado: (2016)

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients
por: DallaPiazza, Michelle, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_l8ec8sbpkpr6di1ktihs95gffm